Enhance Your Research with Real World Evidence Training
Integrating Real World Evidence (RWE) into your Evidence Generation Strategy is a crucial step in advancing medical research and improving patient outcomes. RWE provides insights derived from real-world data sources such as electronic health records, claims data, and patient registries, which complement the findings from traditional clinical trials. This approach helps researchers and healthcare professionals understand the broader impact of treatments and interventions in diverse patient populations and everyday clinical settings.
We offer a 1-day online training sessions hosted by CELforPharma and led by our Co-founder and Scientific Lead Prof. Dr. Thomas Wilke. These sessions aim to equip participants with the knowledge and skills to effectively implement RWE in their research, thereby enhancing their ability to make informed decisions based on comprehensive evidence.
Course Highlights:
Format: 1-day online training
Instructor: Thomas Wilke, Co-founder and Scientific Lead of GIPAM
What You Will Learn:
Stakeholder Expectations: Understand the expectations of external stakeholders regarding RWE throughout the product lifecycle.
Fundamental Concepts: Learn the fundamental concepts, methodologies, and research techniques of RWE in the context of optimising Market Access.
Data Types: Explore the different types of data used in RWE studies, along with their strengths and weaknesses.
Critical Success Factors: Identify the critical success factors necessary for conducting a successful RWE study.
Future Developments: Prepare for new developments in RWE generation to stay ahead in the field.
Why Real World Evidence (RWE)?
Real World Evidence (RWE) is essential for reducing uncertainty among regulators, payers, physicians, and patients. It complements Randomised Controlled Trials (RCTs) by using Real World Data (RWD) from sources such as:
Electronic Health Records (EHRs)
Claims and Billing Activities
Product and Disease Registries
Patient-Generated Data
Mobile Devices
RWE supports regulatory decisions, post-marketing safety monitoring, and treatment effectiveness assessments. It helps healthcare providers make informed decisions and payers with coverage choices.
In this course, you'll learn RWE fundamentals, enabling you to contribute effectively to decision-making and RWE studies. You'll also engage in discussions with international peers and ask questions to an RWE expert.
GIPAM's Expertise
GIPAM offers a variety of services related to RWE and market access strategies. These include:
Designing and Executing RWE Studies: Tailored studies to gather and analyse real-world data.
Strategic Insights for Market Access: Providing guidance to navigate the complexities of market access.
Evidence-Based Frameworks: Developing frameworks to support the value proposition of healthcare interventions.
GIPAM's expertise helps organisations ensure that their products meet the evidence requirements of regulators, payers, and other stakeholders in the healthcare ecosystem.
How to Attend:
Enhance your understanding of RWE and make a real impact in your research and decision-making processes.
To register, please visit www.celforpharma.com.
“The course met all the expectations I had, with a lot of opportunities to ask questions throughout. The wide range of topics covered in depth and the group exercise at the end were valuable for putting what we learned into practice. Dr Wilke was very engaging, and it was clear that he knows the subject really well.”